FDA NDC Directory · JSON-LD · Markdown

Cyclobenzaprine Hydrochloride

NDC 85509-1035 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerPHOENIX RX LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA091281
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsCYCLOBENZAPRINE HYDROCHLORIDE (15 mg/1)
Marketing started20190301
Package count3

External sources

Source: openFDA. Public-domain (CC0).